Theodorus

Theodorus

Brussels, Brussels-Capital Regiontheodorus.be

Overview

Theodorus is a venture capital firm created in 2003 that invests in early-stage projects, primarily spin-offs from the Université Libre de Bruxelles (ULB). It focuses on seed and early-stage funding for companies in the Biotech, MedTech, Digital, and Engineering sectors with proprietary technologies. The firm has managed four funds and has a priority access to R&D outcomes from ULB, but also invests in projects outside the university. As of late 2024, the firm has rebranded to Seido Capital and relocated its headquarters to Montréal, Canada, to focus on the North American life sciences market with its fifth fund. Theodorus has invested in over 40 companies and has more than €70 million under management.

Portfolio Companies

8

Investments

CompanyDateStageLead
Ability BiotherapeuticsJun 2024SeedCo-investor
Simmunome Inc.Sep 2023Pre SeedLead
Flare SystemsNov 2022Series A ExtensionCo-investor
Domain TherapeuticsMay 2022Series A-
HypnoVRDec 2021Series ALead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBrussels, Brussels-Capital Region
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.